Impedimed dosed on sweet medicine
SHARES in Impedimed have jumped after the Brisbane-based biotechnology company received positive medical news about its device, which detects a horrible swelling affliction. Impedimed on Wednesday revealed the American Medical Association had released coding for its device covering the swelling affliction for all cancers, not just breast cancer.